Show simple item record

dc.contributor.advisorYasmin, Hasina
dc.contributor.authorParveen, Sanjana
dc.date.accessioned2022-09-26T05:17:17Z
dc.date.available2022-09-26T05:17:17Z
dc.date.copyright2022
dc.date.issued2022-03
dc.identifier.otherID 17346003
dc.identifier.urihttp://hdl.handle.net/10361/17302
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.en_US
dc.descriptionCataloged from PDF version of thesis report.
dc.descriptionIncludes bibliographical references (pages 60-89).
dc.description.abstractBrain shrinkage and cell death occurs due to Alzheimer's disease, a degenerative neurologic illness. Memory loss, social and behavioral deterioration, and the inability to operate independently are all symptoms of Alzheimer's disease, which is the most frequent cause of dementia. The accumulation of beta amyloid plaque and neurofibrillary tangles are the hallmarks of alzheimer’s disease and conventional treatments only aim to soothe symptoms rather than treat or prevent disease. Presently, the scientific community is working together to find innovative natural compounds that are helpful against Alzheimer's disease and marine natural products have been demonstrated to be potential possibilities. Currently bryostatin-1, homotaurine, dictyostatin, docohexanoic acid, rifampicin, gracilins are being tested for alzheimer’s disease. More clinical trials need to be conducted for marine compounds to be used in alzheimer’s patient. Along with that combination therapy consisting of marine compounds have a prospect of displaying better activity that need to be tested.en_US
dc.description.statementofresponsibilitySanjana Parveen
dc.format.extent89 pages
dc.language.isoenen_US
dc.publisherBrac Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectMarine compoundsen_US
dc.subjectBryostatin-1en_US
dc.subjectHomotaurineen_US
dc.subjectDictyostatinen_US
dc.subjectDocohexanoic aciden_US
dc.subject.lcshAlzheimer’s disease
dc.titleMarine compounds in the treatment of Alzheimer’s diseaseen_US
dc.typeThesisen_US
dc.contributor.departmentDepartment of Pharmacy, Brac University
dc.description.degreeB. Pharmacy


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record